Integrated Physiology and Molecular Medicine Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Department of Nuclear Medicine, Montefiore Medical Center, Bronx, New York, USA.
Obesity (Silver Spring). 2022 Jan;30(1):39-44. doi: 10.1002/oby.23312. Epub 2021 Nov 24.
Metabolically healthy obesity (MHO) is often defined as the absence of metabolic syndrome in the presence of obesity. However, phenotypic features of MHO are unclear. Insulin sensitivity in MHO was cross-sectionally compared with metabolically unhealthy obesity (MUO) and a reference group of young healthy participants without obesity.
Sedentary adults (n = 96) undergoing anthropometric, blood chemistries, maximal aerobic capacity, and euglycemic-hyperinsulinemic clamp measurements were classified by BMI (<25 and ≥30 kg/m ). MUO was defined as having obesity with metabolic syndrome (≥2 additional risk factors). Data were analyzed using a linear mixed models approach.
Body weight was similar between MHO and MUO. Body fat (percentage) and high-density lipoprotein cholesterol were higher (p < 0.001), and systolic blood pressure, triglycerides, glucose, and insulin were lower in MHO versus MUO (p < 0.03, all). The MHO group also had lower high-density lipoprotein cholesterol and higher low-density lipoprotein cholesterol, diastolic blood pressure, and insulin compared with the reference. Both the MHO and MUO groups displayed impaired insulin sensitivity compared with the reference control (p < 0.001).
Participants with MHO had distinct clinical measures related to hypertension, lipid metabolism, and glycemic control compared with a healthy reference group. Peripheral insulin resistance in obesity independent of metabolic status portends increased risk for type 2 diabetes in the MHO patient population.
代谢健康肥胖(MHO)通常被定义为肥胖患者中不存在代谢综合征。然而,MHO 的表型特征尚不清楚。本研究旨在比较 MHO 与代谢不健康肥胖(MUO)以及无肥胖的年轻健康参与者的参考组的胰岛素敏感性。
对接受人体测量、血液化学、最大有氧能力和葡萄糖输注-高胰岛素钳夹测量的久坐成年人(n=96),按 BMI(<25 和≥30 kg/m )进行分类。MUO 的定义为肥胖伴代谢综合征(≥2 个其他危险因素)。使用线性混合模型方法分析数据。
MHO 和 MUO 之间的体重相似。与 MUO 相比,MHO 的体脂(%)和高密度脂蛋白胆固醇更高(p<0.001),而收缩压、甘油三酯、葡萄糖和胰岛素较低(p<0.03,均)。与参考组相比,MHO 组的高密度脂蛋白胆固醇较低,低密度脂蛋白胆固醇、舒张压和胰岛素较高。与参考对照组相比,MHO 和 MUO 组的胰岛素敏感性均受损(p<0.001)。
与健康参考组相比,MHO 参与者具有与高血压、脂代谢和血糖控制相关的独特临床指标。肥胖患者的外周胰岛素抵抗与代谢状态无关,预示着 MHO 患者人群发生 2 型糖尿病的风险增加。